REsearch group on CANCER and Neurodegeneration
RESEARCH SUMMARY :
This group is working on proposals related to the FP7-HEALTH-Cooperation Program:
- HEALTH.2011.2.4.1-1: Investigator-driven, treatment trials24 for rare cancers.
- HEALTH.2011.2.4.1-2: Translational research on cancers with poor prognosis.
Key words : stem cells, solid tumors, chemo and radio therapy resistance, recurrence, therapy of differentiation, new drug development.
Research groups involved:
- UCLM Neuropharmacology Group
- UCLM Neurochemistry Group
- UCLM Laboratory of Human Neuroanatomy
- UCLM Laboratory of molecular oncology
- UCLM Cellular and Molecular Biology of Stem Cell Group
- UMINHO Chemistry Department
- UNILIM Cellular Homeostasis and Pathologies Group
- UMHE Neurosciences Institute, Alterad molecular mechanism in Alzheimer disease
- UPM Centre for Biomedical Technology
- UPNA Health Sciences
- UPNA Statistics and econometrics
External partners
- Adam Mickiewicz University of Poland, Institute of Molecular Biology and Biotechnology
- University of Cambridge, WellcomeTrust Centre for S.C. Research, Epithelial Stem Cell Homeostasis and Cancer Research Group.
- Cambridge Research Center, Mammary Stem Cell Biology Group.
- INBIOMED Regulation of Cell Growth Laboratory – Cancer Programme.
- CORUÑA Hospital, Oncología
Related events:
- 10.03.2010, workshop, Albacete – participants: UCLM, UNILIM, UMINHO, UMHE, Adam Mickiewicz Univ. Poland, Univ. of Cambridge, Cambridge Research Institute, Inbiomed, Coruña hospital.
- 28.04.2010, workshop, Madrid – participants: UPM/UPNA
- Workshop, October 2010, Limoges (to come)
For more information: Joaquin.jordan uclm.es
